Circadian Rhythm Disruption in Cancer Biology

Circadian rhythms show universally a 24-h oscillation pattern in metabolic, physiological and behavioral functions of almost all species. This pattern is due to a fundamental adaptation to the rotation of Earth around its own axis. Molecular mechanisms of generation of circadian rhythms organize a biochemical network in suprachiasmatic nucleus and peripheral tissues, building cell autonomous clock pacemakers. Rhythmicity is observed in transcriptional expression of a wide range of clock-controlled genes that regulate a variety of normal cell functions, such as cell division and proliferation. Desynchrony of this rhythmicity seems to be implicated in several pathologic conditions, including tumorigenesis and progression of cancer. In 2007, the International Agency for Research on Cancer (IARC) categorized “shiftwork that involves circadian disruption (as) probably carcinogenic to humans” (Group 2A in the IARC classification system of carcinogenic potency of an agentagent) (Painting, Firefighting, and Shiftwork; IARC; 2007). This review discusses the potential relation between disruptions of normal circadian rhythms with genetic driving machinery of cancer. Elucidation of the role of clockwork disruption, such as exposure to light at night and sleep disruption, in cancer biology could be important in developing new targeted anticancer therapies, optimizing individualized chronotherapy and modifying lighting environment in workplaces or homes.

[1]  K. Ronacher,et al.  Ligand-selective transactivation and transrepression via the glucocorticoid receptor: Role of cofactor interaction , 2009, Molecular and Cellular Endocrinology.

[2]  E. Nishida,et al.  Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock. , 2000, Genes & development.

[3]  Erik D. Herzog,et al.  A circadian clock in macrophages controls inflammatory immune responses , 2009, Proceedings of the National Academy of Sciences.

[4]  D. P. King,et al.  Mammalian Circadian Autoregulatory Loop A Timeless Ortholog and mPer1 Interact and Negatively Regulate CLOCK-BMAL1-Induced Transcription , 1998, Neuron.

[5]  Fan Wang,et al.  Deregulated Expression of the Per1 and Per2 in Human Gliomas , 2010, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  J. Tímár,et al.  Glucocorticoid Receptor Expression and Antiproliferative Effect of Dexamethasone on Human Melanoma Cells , 2011, Pathology & Oncology Research.

[7]  T. Holford,et al.  Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk , 2008, Breast Cancer Research and Treatment.

[8]  Junjie Chen,et al.  Interactions between DBC1 and SIRT1 are deregulated in breast cancer cells , 2009, Cell cycle.

[9]  Lili Liu,et al.  Hypoxia promotes metastasis in human gastric cancer by up‐regulating the 67‐kDa laminin receptor , 2010, Cancer science.

[10]  W. D. Cress,et al.  Histone deacetylases, transcriptional control, and cancer , 2000, Journal of cellular physiology.

[11]  Patricia A. Wood,et al.  Clock Genes and Cancer , 2009, Integrative cancer therapies.

[12]  C. McClung,et al.  Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges , 2009, Brain Research Reviews.

[13]  M. Antoch,et al.  Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis , 2008, Cell cycle.

[14]  D. Bechtold,et al.  Setting Clock Speed in Mammals: The CK1ɛ tau Mutation in Mice Accelerates Circadian Pacemakers by Selectively Destabilizing PERIOD Proteins , 2008, Neuron.

[15]  B. Jung-Hynes,et al.  Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer , 2009, Journal of Biological Chemistry.

[16]  Takako Noguchi,et al.  Tip60 Is Regulated by Circadian Transcription Factor Clock and Is Involved in Cisplatin Resistance* , 2008, Journal of Biological Chemistry.

[17]  Zissimos Mourelatos,et al.  The microRNA world: small is mighty. , 2003, Trends in biochemical sciences.

[18]  D. Ray,et al.  Loss of Glucocorticoid Receptor Expression by DNA Methylation Prevents Glucocorticoid Induced Apoptosis in Human Small Cell Lung Cancer Cells , 2011, PloS one.

[19]  Cheng Chi Lee.  The circadian clock and tumor suppression by mammalian period genes. , 2005, Methods in enzymology.

[20]  S. Gery,et al.  A role for the clock gene per1 in prostate cancer. , 2009, Cancer research.

[21]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[22]  G. Eichele,et al.  Transcriptional Profiling in the Adrenal Gland Reveals Circadian Regulation of Hormone Biosynthesis Genes and Nucleosome Assembly Genes , 2006, Journal of biological rhythms.

[23]  J. Stanford,et al.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. , 2009, Cancer research.

[24]  F. Lévi,et al.  Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability , 2011, Cancer Chemotherapy and Pharmacology.

[25]  S. Kyrylenko,et al.  Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases , 2003, Cellular and Molecular Life Sciences CMLS.

[26]  M. Straume,et al.  Daily timed meals dissociate circadian rhythms in hepatoma and healthy host liver , 2006, International journal of cancer.

[27]  N. Yaegashi,et al.  Clinicopathological significance of circadian rhythm‐related gene expression levels in patients with epithelial ovarian cancer , 2008, Acta obstetricia et gynecologica Scandinavica.

[28]  V. Cassone,et al.  Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver. , 2009, Toxicology and applied pharmacology.

[29]  J. Grutsch,et al.  Circadian Clock Manipulation for Cancer Prevention and Control and the Relief of Cancer Symptoms , 2009, Integrative cancer therapies.

[30]  J. Goodman,et al.  Hypomethylation of DNA: a possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis. , 1993, Environmental health perspectives.

[31]  Wei Zhang,et al.  The role of polymorphisms in circadian pathway genes in breast tumorigenesis , 2011, Breast Cancer Research and Treatment.

[32]  G. Brandi,et al.  Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. , 2004, Cancer letters.

[33]  C. Rodríguez,et al.  Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion , 2008, Journal of pineal research.

[34]  S. Krager,et al.  Circadian clock disruption in the mouse ovary in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 2011, Toxicology letters.

[35]  K. Tomioka,et al.  Molecular cloning and functional analysis of the clock genes, Clock and cycle, in the firebrat Thermobia domestica. , 2010, Journal of insect physiology.

[36]  R. Faustino,et al.  Ceramide regulation of nuclear protein imports⃞ Published, JLR Papers in Press, December 14, 2007. , 2008, Journal of Lipid Research.

[37]  C. Perez-Iratxeta,et al.  miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. , 2011, Human molecular genetics.

[38]  H. Y. Lin,et al.  Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3 , 2006, Cancer science.

[39]  R. Stevens.  Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. , 2009, International journal of epidemiology.

[40]  D. Christiani,et al.  Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma , 2008, Cancer.

[41]  A. Andriulli,et al.  Clock Gene Expression Levels and Relationship With Clinical and Pathological Features in Colorectal Cancer Patients , 2011, Chronobiology international.

[42]  C. Colwell,et al.  Influence of the estrous cycle on clock gene expression in reproductive tissues: Effects of fluctuating ovarian steroid hormone levels , 2010, Steroids.

[43]  D. Earnest,et al.  The clock genes period 1 and period 2 mediate diurnal rhythms in dioxin-induced Cyp1A1 expression in the mouse mammary gland and liver. , 2010, Toxicology letters.

[44]  T. Kawamoto,et al.  Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system. , 2004, The Biochemical journal.

[45]  W. Feng,et al.  Overexpression of Apg-2 increases cell proliferation and protects from oxidative damage in BaF3-BCR/ABL cells. , 2010, International journal of oncology.

[46]  S. Linn,et al.  Apurinic/apyrimidinic endonucleases in repair of pyrimidine dimers and other lesions in DNA. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Mintz,et al.  Temporal patterns of light-induced immediate-early gene expression in the suprachiasmatic nucleus , 2009, Neuroscience Letters.

[48]  Erin L. McDearmon,et al.  Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation , 2007, Proceedings of the National Academy of Sciences.

[49]  Paolo Sassone-Corsi,et al.  Circadian Clock and Breast Cancer: A Molecular Link , 2007, Cell cycle.

[50]  G. Mazzoccoli,et al.  Altered time structure of neuro-endocrine-immune system function in lung cancer patients , 2010, BMC Cancer.

[51]  F. Lévi,et al.  Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer , 2009, Cancer.

[52]  F. Delaunay,et al.  The nuclear hormone receptor family round the clock. , 2008, Molecular endocrinology.

[53]  Xun Zhang,et al.  Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue , 2008, Cancer Prevention Research.

[54]  Raquel Soares,et al.  Elucidating progesterone effects in breast cancer: Cross talk with PDGF signaling pathway in smooth muscle cell , 2007, Journal of cellular biochemistry.

[55]  T. Gasiewicz,et al.  The Aryl Hydrocarbon Receptor Agonist 2,3,7,8-Tetrachlorodibenzo-p-dioxin Alters the Circadian Rhythms, Quiescence, and Expression of Clock Genes in Murine Hematopoietic Stem and Progenitor Cells , 2006, Molecular Pharmacology.

[56]  Mark S. Rea,et al.  Light in the Built Environment: Potential role of Circadian Disruption in Endocrine Disruption and Breast Cancer , 2001, Cancer Causes & Control.

[57]  P. Aisen,et al.  Transferrin receptor 1. , 2004, The international journal of biochemistry & cell biology.

[58]  R. Stevens,et al.  Total visual blindness is protective against breast cancer , 2009, Cancer Causes & Control.

[59]  C. Heldin,et al.  Platelet-derived growth factor receptor-β, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma , 2007, BMC Cancer.

[60]  H. Leonhardt,et al.  DNA methylation‐mediated epigenetic control , 2009, Journal of cellular biochemistry.

[61]  M. Mattson,et al.  Anti-apoptotic Role of Telomerase in Pheochromocytoma Cells* , 1999, The Journal of Biological Chemistry.

[62]  X. Wang,et al.  Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice , 2007, Cancer Gene Therapy.

[63]  G. V. D. van der Horst,et al.  DNA Repair in Mammalian Cells , 2009, Cellular and Molecular Life Sciences.

[64]  Richard G. Stevens,et al.  Circadian Disruption and Breast Cancer: From Melatonin to Clock Genes , 2005, Epidemiology.

[65]  F. Yuan,et al.  Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair* , 2004, Journal of Biological Chemistry.

[66]  S. Honma,et al.  Light responsiveness of clock genes, Per1 and Per2, in the olfactory bulb of mice. , 2011, Biochemical and biophysical research communications.

[67]  J. Sheehan,et al.  Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: Is there a difference in outcome between morning and afternoon treatment? , 2011, Cancer.

[68]  Hosung Jung,et al.  Involvement of CLOCK:BMAL1 heterodimer in serum-responsive mPer1 induction , 2003, Neuroreport.

[69]  M. A. Rol,et al.  Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma‐bearing C57BL6 mice , 2008, Journal of pineal research.

[70]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[71]  F Laden,et al.  Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. , 2001, Journal of the National Cancer Institute.

[72]  S. Yamaguchi,et al.  Control Mechanism of the Circadian Clock for Timing of Cell Division in Vivo , 2003, Science.

[73]  Peter Woolf,et al.  Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. , 2005, Molecular and cellular biology.

[74]  Yi-Chang Liu,et al.  Altered Expression of Circadian Clock Genes in Human Chronic Myeloid Leukemia , 2011, Journal of biological rhythms.

[75]  Cathleen Brdlik,et al.  Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest , 2006, Proceedings of the National Academy of Sciences.

[76]  A. Sancar,et al.  Circadian regulation of DNA excision repair: Implications for chrono-chemotherapy , 2009, Cell cycle.

[77]  L. Allen.  Stem cells. , 2003, The New England journal of medicine.

[78]  R. Paro,et al.  Multi-author Review¶Epigenetic control of transcription¶Introduction: the genetics of epigenetics , 1998, Cellular and Molecular Life Sciences CMLS.

[79]  Javier Martinez,et al.  MicroRNAs cross the line: the battle for mRNA stability enters the coding sequence. , 2009, Molecular cell.

[80]  M. Antoch,et al.  BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. , 2003, Genes & development.

[81]  L. Fuentes-Broto,et al.  Melatonin: a multitasking molecule. , 2010, Progress in brain research.

[82]  U. Albrecht.  Orchestration of gene expression and physiology by the circadian clock , 2006, Journal of Physiology-Paris.

[83]  Peter Woolf,et al.  Control of Mammalian Circadian Rhythm by CKIε-Regulated Proteasome-Mediated PER2 Degradation , 2005, Molecular and Cellular Biology.

[84]  Tripp Frasch,et al.  Molecular Mechanisms of Melatonin Anticancer Effects , 2009, Integrative cancer therapies.

[85]  Ming-Feng Hou,et al.  Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. , 2005, Carcinogenesis.

[86]  R. Foster,et al.  Sleep and circadian rhythm disturbances: multiple genes and multiple phenotypes. , 2009, Current opinion in genetics & development.

[87]  E. Kallay,et al.  Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. , 2007, Cancer research.

[88]  D. Meruelo,et al.  Extraribosomal functions associated with the C terminus of the 37/67 kDa laminin receptor are required for maintaining cell viability , 2010, Cell Death and Disease.

[89]  S. Yin,et al.  Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer , 2009, Advances in therapy.

[90]  K. Kadota,et al.  Genome-wide Expression Analysis of Mouse Liver Reveals CLOCK-regulated Circadian Output Genes* , 2003, Journal of Biological Chemistry.

[91]  L. Meijer,et al.  Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. , 2006, Cancer research.

[92]  R. Klevecz,et al.  Circadian gating of S phase in human ovarian cancer. , 1987, Cancer research.

[93]  T. Kawamoto,et al.  A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation. , 2004, Biochemical and biophysical research communications.

[94]  A. Prombona,et al.  THE CIRCADIAN EXPRESSION OF c-MYC IS MODULATED BY THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A IN SYNCHRONIZED MURINE NEUROBLASTOMA CELLS , 2010, Chronobiology international.

[95]  F. Tamanini,et al.  The BMAL1 C terminus regulates the circadian transcription feedback loop. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[96]  E. Kallay,et al.  Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer , 2009, Molecular carcinogenesis.

[97]  D. Mirick,et al.  Circadian Disruption, Shift Work and the Risk of Cancer: A Summary of the Evidence and Studies in Seattle , 2006, Cancer Causes & Control.

[98]  Hong Wu,et al.  Downregulation of 15-lipoxygenase 2 by glucocorticoid receptor in prostate cancer cells. , 2010, International journal of oncology.

[99]  Jun Qin,et al.  Involvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis , 2000, Cell.

[100]  W. Hrushesky,et al.  Circadian Time-Dependent Tumor Suppressor Function of Period Genes , 2009, Integrative cancer therapies.

[101]  G. Chrousos,et al.  Peripheral CLOCK Regulates Target-Tissue Glucocorticoid Receptor Transcriptional Activity in a Circadian Fashion in Man , 2011, PloS one.

[102]  Franck Delaunay,et al.  The Circadian Clock Component BMAL1 Is a Critical Regulator of p21WAF1/CIP1 Expression and Hepatocyte Proliferation* , 2008, Journal of Biological Chemistry.

[103]  Y. Shigeyoshi,et al.  Circadian rhythm generation in a glioma cell line. , 2006, Biochemical and biophysical research communications.

[104]  Oren Froy,et al.  Metabolism and circadian rhythms--implications for obesity. , 2010, Endocrine reviews.

[105]  S. Cross,et al.  Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma , 2008, Clinical Cancer Research.

[106]  S. Lundgren,et al.  Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype , 2009, PloS one.

[107]  John P. Hanifin,et al.  Circadian Stage-Dependent Inhibition of Human Breast Cancer Metabolism and Growth by the Nocturnal Melatonin Signal: Consequences of Its Disruption by Light at Night in Rats and Women , 2009, Integrative cancer therapies.

[108]  S. Linton,et al.  Pain, disability and coping reflected in the diurnal cortisol variability in patients scheduled for lumbar disc surgery , 2008, European journal of pain.

[109]  P. Ganz,et al.  Altered Cortisol Response to Psychologic Stress in Breast Cancer Survivors With Persistent Fatigue , 2005, Psychosomatic medicine.

[110]  I. Andrulis,et al.  Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. , 2007, Neoplasia.

[111]  U. Schibler,et al.  A Serum Shock Induces Circadian Gene Expression in Mammalian Tissue Culture Cells , 1998, Cell.

[112]  Steven M Reppert,et al.  mCRY1 and mCRY2 Are Essential Components of the Negative Limb of the Circadian Clock Feedback Loop , 1999, Cell.

[113]  Minoru Tanaka,et al.  Positional Cloning of the Mouse Circadian Clock Gene , 1997, Cell.

[114]  Stefan Thurner,et al.  Short‐term rhythmic proliferation of human breast cancer cell lines: surface effects and fractal growth patterns , 2002, The Journal of pathology.

[115]  T. Sen,et al.  Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa) , 2011, Journal of Cancer Research and Clinical Oncology.

[116]  M. Dubocovich,et al.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors , 2010, Pharmacological Reviews.

[117]  L. Donehower,et al.  Disrupting Circadian Homeostasis of Sympathetic Signaling Promotes Tumor Development in Mice , 2010, PloS one.

[118]  Zhiwei Wang,et al.  miR‐200 Regulates PDGF‐D‐Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells , 2009, Stem cells.

[119]  R. Reiter,et al.  Protective action of melatonin against oxidative DNA damage: chemical inactivation versus base-excision repair. , 2007, Mutation research.

[120]  V. Cassone,et al.  Disruption of Clock Gene Expression Alters Responses of the Aryl Hydrocarbon Receptor Signaling Pathway in the Mouse Mammary Gland , 2007, Molecular Pharmacology.

[121]  L. Roncucci,et al.  Myeloperoxidase-Positive Cell Infiltration in Colorectal Carcinogenesis as Indicator of Colorectal Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[122]  R. Jamasbi,et al.  Elevated mPer1 gene expression in tumor stroma imaged through bioluminescence , 2010, International journal of cancer.

[123]  James Lyons-Weiler,et al.  Molecular overlap of fly circadian rhythms and human pancreatic cancer. , 2006, Cancer letters.

[124]  K. Glaser,et al.  Differential protein acetylation induced by novel histone deacetylase inhibitors. , 2004, Biochemical and biophysical research communications.

[125]  Paolo Sassone-Corsi,et al.  The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control , 2008, Cell.

[126]  D. Meruelo,et al.  Interactions Between Laminin Receptor and the Cytoskeleton During Translation and Cell Motility , 2011, PloS one.

[127]  Pengbo Zhou,et al.  Navigating the nucleotide excision repair threshold , 2010, Journal of cellular physiology.

[128]  T. Nonaka,et al.  The synchronization of chemotherapy to circadian rhythms and irradiation in pre-operative chemoradiation therapy with hyperthermia for local advanced rectal cancer. Abbreviations: 5-FU 5-fluorouracil LV Leucovorin APR abdomino-perineal resection , 2006, International Journal of Hyperthermia.

[129]  G. Berx,et al.  Modulation of iron transport proteins in human colorectal carcinogenesis , 2006, Gut.

[130]  W. Hrushesky,et al.  Circadian organization of thymidylate synthase activity in normal tissues: A possible basis for 5‐fluorouracil chronotherapeutic advantage , 2000, International journal of cancer.

[131]  T. Tamai,et al.  Light signaling to the zebrafish circadian clock by Cryptochrome 1a , 2007, Proceedings of the National Academy of Sciences.

[132]  A. Nakashima,et al.  DEC1 Modulates the Circadian Phase of Clock Gene Expression , 2008, Molecular and Cellular Biology.

[133]  S. Ohdo,et al.  Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice. , 2010, Cancer research.

[134]  S. Ohdo,et al.  Modulation of circadian rhythm of DNA synthesis in tumor cells by inhibiting platelet-derived growth factor signaling. , 2008, Journal of pharmacological sciences.

[135]  J. Sears,et al.  Diurnal rhythm of the chromatin protein Hmgb1 in rat photoreceptors is under circadian regulation , 2007, The Journal of comparative neurology.

[136]  H. Kim,et al.  Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells , 2005, Molecular and Cellular Biology.

[137]  Jan-Gowth Chang,et al.  Promoter methylation in circadian genes of endometrial cancers detected by methylation‐specific PCR , 2006, Molecular carcinogenesis.

[138]  Steven M. Reppert,et al.  Differential Functions of mPer1, mPer2, and mPer3 in the SCN Circadian Clock , 2001, Neuron.

[139]  K Kume,et al.  Interacting molecular loops in the mammalian circadian clock. , 2000, Science.

[140]  T. Kino,et al.  Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[141]  Xun Zhang,et al.  Methylselenocysteine Resets the Rhythmic Expression of Circadian and Growth-Regulatory Genes Disrupted by Nitrosomethylurea In vivo , 2010, Cancer Prevention Research.

[142]  S. Ohdo,et al.  Chronopharmacological strategies: Intra- and inter-individual variability of molecular clock. , 2010, Advanced drug delivery reviews.

[143]  S. Amir,et al.  The effectiveness of light on the circadian clock is linked to its emotional value , 1999, Neuroscience.

[144]  Seung-Hee Yoo,et al.  Rhythmic PER abundance defines a critical nodal point for negative feedback within the circadian clock mechanism. , 2009, Molecular cell.

[145]  F. Lévi,et al.  Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.

[146]  E. Yukawa,et al.  Chronopharmacology of antitumor effect induced by interferon-beta in tumor-bearing mice. , 2000, The Journal of pharmacology and experimental therapeutics.

[147]  K. Fujimoto,et al.  Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-alpha. , 2008, Biomedical research.

[148]  S. Rusconi,et al.  Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK , 2008, BMC Molecular Biology.

[149]  C. Kirschbaum,et al.  Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer , 2010, Cancer.

[150]  K. Fazekas.  [Regulation of the cell cycle]. , 1998, Orvosi hetilap.

[151]  K. Yagita,et al.  Brain expression of apurinic/apyrimidinic endonuclease (APE/Ref-1) multifunctional DNA repair enzyme gene in the mouse with special reference to the suprachiasmatic nucleus , 2003, Neuroscience Research.

[152]  S. Dickerson,et al.  Diurnal cortisol rhythm and fatigue in breast cancer survivors , 2005, Psychoneuroendocrinology.

[153]  B. Zhu,et al.  RACK1, a novel hPER1-interacting protein , 2007, Journal of Molecular Neuroscience.

[154]  D. Clesse,et al.  Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent , 2008, Experimental Neurology.

[155]  T. Kawamoto,et al.  Dec1 and Dec2 Expression is Disrupted in the Suprachiasmatic Nuclei of Clock Mutant Mice , 2004, Journal of biological rhythms.

[156]  Mark S. Rea,et al.  Meeting Report: The Role of Environmental Lighting and Circadian Disruption in Cancer and Other Diseases , 2007, Environmental health perspectives.

[157]  E. Alnemri,et al.  Modulator inhibits nuclear translocation of the glucocorticoid receptor and inhibits glucocorticoid-induced apoptosis in the human leukemic cell line CEM C-7. , 1995, Cancer research.

[158]  T. Kawamoto,et al.  Dec1 and Dec2 are regulators of the mammalian molecular clock , 2002, Nature.

[159]  Giuseppe Tonini,et al.  Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.

[160]  Shuji Ogino,et al.  SIRT1 Histone Deacetylase Expression Is Associated with Microsatellite Instability and CpG Island Methylator Phenotype in Colorectal Cancer , 2009, Modern Pathology.

[161]  Kai Yu,et al.  Correlation between Circadian Gene Variants and Serum Levels of Sex Steroids and Insulin-like Growth Factor-I , 2008, Cancer Epidemiology Biomarkers & Prevention.

[162]  Shou‐Tung Chen,et al.  Disturbance of circadian gene expression in breast cancer , 2009, Virchows Archiv.

[163]  Shadab A. Rahman,et al.  Prevention of melatonin suppression by nocturnal lighting: relevance to cancer , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[164]  R. Virk,et al.  The clock gene Per2 links the circadian system to the estrogen receptor , 2007, Oncogene.

[165]  F. Lévi,et al.  Circadian disruption accelerates liver carcinogenesis in mice. , 2009, Mutation research.

[166]  R. Eferl,et al.  Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge , 2009, Oncogene.

[167]  E. Epel,et al.  Flattened cortisol rhythms in metastatic breast cancer patients , 2004, Psychoneuroendocrinology.

[168]  S. Higuchi,et al.  24-Hour Oscillation of Mouse Methionine Aminopeptidase2, a Regulator of Tumor Progression, Is Regulated by Clock Gene Proteins , 2004, Cancer Research.

[169]  E. Yukawa,et al.  Relationship between diurnal rhythm of cell cycle and interferon receptor expression in implanted-tumor cells. , 2001, Life sciences.

[170]  R. Martienssen,et al.  Distinct Mechanisms Determine Transposon Inheritance and Methylation via Small Interfering RNA and Histone Modification , 2003, PLoS biology.

[171]  D. Virshup,et al.  Nuclear Export of Mammalian PERIOD Proteins* , 2001, The Journal of Biological Chemistry.

[172]  E. Lam,et al.  Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[173]  Qian Zhang,et al.  Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor , 2008, Proceedings of the National Academy of Sciences.

[174]  F. Dhabhar,et al.  Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer , 2009, Brain, Behavior, and Immunity.

[175]  D. Mottet,et al.  Histone deacetylases: target enzymes for cancer therapy , 2007, Clinical & Experimental Metastasis.

[176]  A. Sancar,et al.  Circadian oscillation of nucleotide excision repair in mammalian brain , 2009, Proceedings of the National Academy of Sciences.

[177]  G. Chrousos,et al.  Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: Circadian rhythm-associated alterations of glucocorticoid actions in target tissues , 2011, Molecular and Cellular Endocrinology.

[178]  S. Krager,et al.  Disruption of CLOCK-BMAL1 transcriptional activity is responsible for aryl hydrocarbon receptor-mediated regulation of Period1 gene. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[179]  I. Leiros,et al.  DNA Repair in Mammalian Cells , 2009, Cellular and Molecular Life Sciences.

[180]  W. Hrushesky,et al.  Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index , 2006, Molecular Cancer Therapeutics.

[181]  O. Fardel,et al.  Involvement of aryl hydrocarbon receptor in basal and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced expression of target genes in primary human hepatocytes. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[182]  Patricia A. Wood,et al.  Daily coordination of cancer growth and circadian clock gene expression , 2005, Breast Cancer Research and Treatment.

[183]  S. Conzen,et al.  Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. , 2011, Cancer research.

[184]  Xiaoming Yang,et al.  Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. , 2009, Journal of biochemistry.

[185]  Samuel Bernard,et al.  Tumor Growth Rate Determines the Timing of Optimal Chronomodulated Treatment Schedules , 2010, PLoS Comput. Biol..

[186]  S. Gery,et al.  The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. , 2006, Molecular cell.

[187]  Stefano Iacobelli,et al.  Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer , 2005, Clinical Cancer Research.

[188]  F. Lévi,et al.  Chronotherapy and the molecular clock: Clinical implications in oncology. , 2010, Advanced drug delivery reviews.

[189]  T. Rikiyama,et al.  Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. , 2009, Anticancer research.

[190]  Y. Sasaguri,et al.  Circadian Disruption Accelerates Tumor Growth and Angio/Stromagenesis through a Wnt Signaling Pathway , 2010, PloS one.

[191]  I. Komuro,et al.  Bradykinin-Induced Microglial Migration Mediated by B1-Bradykinin Receptors Depends on Ca2+ Influx via Reverse-Mode Activity of the Na+/Ca2+ Exchanger , 2007, The Journal of Neuroscience.

[192]  P. Boyle,et al.  Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non‐Hodgkin's lymphoma , 2007, International journal of cancer.

[193]  A. Loudon,et al.  Circadian timing in the lung; a specific role for bronchiolar epithelial cells. , 2009, Endocrinology.

[194]  Xiaoming Yang,et al.  Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm , 2009, Breast Cancer Research and Treatment.

[195]  Stefano Iacobelli,et al.  Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[196]  A. Kalsbeek,et al.  Effects of Nocturnal Light on (Clock) Gene Expression in Peripheral Organs: A Role for the Autonomic Innervation of the Liver , 2009, PloS one.

[197]  E. Ballestar,et al.  Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. , 2009, Cancer research.

[198]  Takanobu Nakazawa,et al.  microRNA Modulation of Circadian-Clock Period and Entrainment , 2007, Neuron.

[199]  B. Jung-Hynes,et al.  Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells , 2010, Journal of pineal research.

[200]  D. W. Green,et al.  Targeted Suppression of β-Catenin Blocks Intestinal Adenoma Formation in APC Min Mice , 2008, Journal of Gastrointestinal Surgery.

[201]  A. Wirz-Justice,et al.  High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. , 2005, The Journal of clinical endocrinology and metabolism.

[202]  R. Agarwal.  Regulation of circadian blood pressure: from mice to astronauts , 2010, Current opinion in nephrology and hypertension.

[203]  Patricia A. Wood,et al.  THE CIRCADIAN CLOCK GENE PER1 SUPPRESSES CANCER CELL PROLIFERATION AND TUMOR GROWTH AT SPECIFIC TIMES OF DAY , 2009, Chronobiology international.

[204]  G. Cornelissen,et al.  Circadian telomerase activity and DNA synthesis for timing peptide administration , 2003, Peptides.

[205]  C. Roberts,et al.  Epigenetics and Cancer: Altered Chromatin Remodeling via Snf5 Loss Leads to Aberrant Cell Cycle Regulation , 2006, Cell cycle.

[206]  Rajeev Gupta,et al.  Circadian variation in radiation‐induced intestinal mucositis in patients with cervical carcinoma , 2010, Cancer.

[207]  Theodore R Holford,et al.  Molecular and Cellular Pathobiology Transcriptional Profiling Analyses , 2022 .

[208]  K. Leach,et al.  Glucocorticoid receptor activation and inactivation in cultured human lymphocytes. , 1981, The Journal of biological chemistry.

[209]  Brent R Stockwell,et al.  Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest , 2008, Genome Biology.

[210]  H. Abu-Soud,et al.  Melatonin is a potent inhibitor for myeloperoxidase. , 2008, Biochemistry.